MBP metabolic pharmaceuticals limited

csiro: polynovo cost benefit analysis, page-9

  1. 18,797 Posts.
    lightbulb Created with Sketch. 1730
    Hang in thee Mowbray..I think this, ZYL and JRV will come good

    All our portfolios aren't looking too flash right now..but things change

    All the best
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.